Description
SaiyanMed Research Material
Cartalax
Fibroblast replicative-aging models · Sirtuin and collagen-I expression
Cartalax is an AED tripeptide appearing in the literature on ultrashort peptide regulation. The most directly accessible original research examines sirtuin and collagen-I expression in aging human skin fibroblast cultures, while review-level work places AED within broader investigations of cellular differentiation and peptide–transporter interactions.
Sirtuin and collagen-I expression
Exploratory transporter modeling
Laboratory material
Research use only
RESEARCH CONTEXT
Fibroblast replicative-aging models
Evidence is sparse. The 2022 review’s cartilage-protection label cites RU2299741C1, a patent, rather than a clinical cartilage-repair trial. Joint regeneration, arthritis treatment and anti-aging efficacy in humans are not established. The comparative study’s inflammatory findings for KE are not evidence of the same activity for AED.
Batch-specific documentation
RUO
Research Context
Fibroblast replicative-aging models
An original study compared AED and KE peptides in cultured human skin fibroblasts during replicative aging using immunocytochemistry and confocal microscopy.
Sirtuin and collagen-I expression
Exploratory transporter modeling
What is Cartalax?
Cartalax is the ultrashort tripeptide Ala-Glu-Asp (AED), identified by this name and sequence in peptide-regulation reviews. Cartalax is an AED tripeptide appearing in the literature on ultrashort peptide regulation. The most directly accessible original research examines sirtuin and collagen-I expression in aging human skin fibroblast cultures, while review-level work places AED within broader investigations of cellular differentiation and peptide–transporter interactions.
The AED study reported increased synthesis of sirtuin-1, sirtuin-6 and collagen I in cultured fibroblasts. These are cellular protein-expression endpoints, not evidence of skin rejuvenation in people. A 2022 review includes Cartalax/AED in a LAT1 docking table. A predicted interaction is a hypothesis for experimental transport studies, not demonstrated uptake or bioavailability.
Evidence is sparse. The 2022 review’s cartilage-protection label cites RU2299741C1, a patent, rather than a clinical cartilage-repair trial. Joint regeneration, arthritis treatment and anti-aging efficacy in humans are not established. The comparative study’s inflammatory findings for KE are not evidence of the same activity for AED.
🧪 Research Applications
①
Fibroblast replicative-aging models
An original study compared AED and KE peptides in cultured human skin fibroblasts during replicative aging using immunocytochemistry and confocal microscopy.
②
Sirtuin and collagen-I expression
The AED study reported increased synthesis of sirtuin-1, sirtuin-6 and collagen I in cultured fibroblasts. These are cellular protein-expression endpoints, not evidence of skin rejuvenation in people.
③
Exploratory transporter modeling
A 2022 review includes Cartalax/AED in a LAT1 docking table. A predicted interaction is a hypothesis for experimental transport studies, not demonstrated uptake or bioavailability.
④
Analytical Characterization
Assess material identity, composition, and method suitability using documentation for the exact sample; published research does not certify the commercial lot.
⑤
Study Interpretation
Interpret experimental results within the tested model and endpoint. Constituent or reference-compound findings do not establish clinical effects of this material.
⑥
Material Traceability
Match laboratory records and any supplier report to the exact labeled material and lot.
📊 Quick Specs
Quality Documentation
Certificate of Analysis (COA)
A Certificate of Analysis records the identity checks, analytical methods and results reported for a specific sample or batch. Explore published quality reports in the SaiyanMed Trust Center.
For product or batch documentation enquiries, contact SaiyanMed with the product name and lot number, where available.
📦 Storage & Handling
Reference handling recommendation — only if supplied as a lyophilizate
For lyophilized reference peptides, Bachem recommends a tightly closed container below −15°C, with lower temperatures preferred for longer storage. Let the sealed vial reach ambient temperature in a desiccator before opening to limit moisture uptake.
Reference handling recommendation — peptide solution
For peptide solutions, select a suitable buffer, divide into single-use aliquots and keep frozen below −15°C following the cited general peptide guide. Avoid prolonged solution storage and repeated freeze–thaw cycles; set the stability window for the actual sample and experiment.
🚚 Fulfillment & Transit Notice
Global logistics: Orders ship from the nearest available warehouse. US-based warehouse fulfillment is available for domestic US orders; international orders ship from our Asian logistics hub with an estimated 7–14 day global delivery window. Delivery estimates may vary with destination, carrier and customs processing.
Temperature in transit: Follow the storage and handling guidance for the product’s supplied form upon arrival. Dry peptides, prepared solutions and liquid formulations have different handling requirements; contact us with the product and order reference if you have concerns about transit conditions.
Customs & duties: Cross-border research-chemical shipments may occasionally be subject to customs inspection or delay. Import duties and local customs requirements remain the responsibility of the consignee. A customs hold does not by itself indicate a product issue.
Delays or holds: If a shipment is delayed beyond the estimated window or held in customs, contact us with your order reference. We will assist with tracking and, where applicable, arrange a reshipment in line with our shipping policy.
Damaged or incorrect items: Please inspect your order on arrival. If a vial is damaged or an item is incorrect, contact us within the period stated in our shipping policy, with photos, for prompt resolution.
⚠️
Research Use Only
This material is supplied only for qualified laboratory research and is not intended for human or veterinary use.
Research Use Only
Not for Human Consumption
This listing is for laboratory research only. It is not intended for diagnostic, therapeutic, medical, disease-prevention, consumer-health, or personal use.
It is not for human consumption, medical treatment, diagnosis, disease prevention, or veterinary use.
✅ Buyer Confirmation
✓ You are a qualified researcher or acting under one’s supervision.
✓ The material will be used only for legitimate laboratory research.
✓ No human-use approval, efficacy, or safety claim is made for this listing.
✓ You are responsible for applicable laws and institutional procedures.
No Warranty: Product-specific identity, quality, safety, and suitability are not independently established by this page. Research outcomes and interpretations depend on the material and study design.
🛡️ General Safety & Handling
🚫 Not for Human Use
For qualified laboratory research only; not for human or veterinary administration.
🥽 PPE Required
Use appropriate personal protective equipment and institutional laboratory controls.
🌡 Follow Lot Documentation
Product-specific storage and stability details are not supplied on this listing.
🗑 Proper Disposal
Follow institutional biosafety and waste-disposal procedures.
🧾 Verify the Lot
Do not assume product identity or purity without batch-matched documentation.
⚖ Legal Compliance
Researchers are responsible for lawful possession and use in their jurisdiction.
💬 Frequently Asked Questions
Can Cartalax replace Epithalon because their sequences are similar?+
No—Cartalax is AED, while Epithalon is AEDG. The extra residue makes Epithalon a different peptide, so choose the exact sequence your experiment requires.
My reference lists AED or Ala-Glu-Asp rather than Cartalax—do they match?+
AED and Ala-Glu-Asp describe the reference sequence associated with Cartalax. Match the full chemical form too, rather than using the three-letter abbreviation alone to identify a material.
Is an acetylated or amidated AED peptide equivalent to Cartalax?+
The Cartalax reference has free terminal groups, so acetylated or amidated AED is a different chemical form. Use the form your protocol specifies rather than treating end-group modifications as a packaging difference.
Can I use a solvent intended for another short peptide with Cartalax?+
Not without checking compatibility with Cartalax and your assay. Short peptide length alone does not establish that water, acidic solutions or other laboratory solvents can be exchanged freely.
📚 References
Comparison of the Effects of KE and AED Peptides on Functional Activity of Human Skin Fibroblasts during Their Replicative Aging (2020; PMID 33231794)
Read source ↗
Reference context only; not a certificate or batch test for this product.
Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers (2022; PMID 35887081)
Read source ↗
Reference context only; not a certificate or batch test for this product.
Peptide Regulation of Gene Expression: A Systematic Review (2021; PMID 34834147)
Read source ↗
Reference context only; not a certificate or batch test for this product.
Specification & handling references
Technical reference ↗
Technical reference ↗





Reviews
There are no reviews yet.